19603018

Source:http://linkedlifedata.com/resource/pubmed/id/19603018

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0009221, umls-concept:C0026882, umls-concept:C0036525, umls-concept:C0123931, umls-concept:C0681842, umls-concept:C0683598, umls-concept:C0812241, umls-concept:C0995188, umls-concept:C1522484, umls-concept:C1527249, umls-concept:C1537502
pubmed:issue	4
pubmed:dateCreated	2009-8-12
pubmed:abstractText	KRAS codons 12 and 13 mutations predict resistance to anti-EGFR monoclonal antibodies (moAbs) in metastatic colorectal cancer. Also, BRAF V600E mutation has been associated with resistance. Additional KRAS mutations are described in CRC.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-10655437, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-15035987, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-15269313, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-15843421, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-16618717, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-16969076, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-17470858, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-17664471, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-18003960, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-18073111, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-18316791, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-18804418, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-18806830, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-18946061, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-19001320, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-19114685, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-19179548, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-19188670, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-19196673, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-19273699, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-19339720, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-19398573, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-20160721, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-2547513, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603018-3043178
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370635
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/BRAF protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin, http://linkedlifedata.com/resource/pubmed/chemical/Codon, http://linkedlifedata.com/resource/pubmed/chemical/KRAS protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins B-raf, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/cetuximab, http://linkedlifedata.com/resource/pubmed/chemical/irinotecan, http://linkedlifedata.com/resource/pubmed/chemical/ras Proteins
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1532-1827
pubmed:author	pubmed-author:BasoloFF, pubmed-author:BencardinoKK, pubmed-author:CanestrariEE, pubmed-author:CatalanoVV, pubmed-author:CremoliniCC, pubmed-author:FalconeAA, pubmed-author:FlorianiII, pubmed-author:FontaniniGG, pubmed-author:GalluccioNN, pubmed-author:GrazianoFF, pubmed-author:LoupakisFF, pubmed-author:MagnaniMM, pubmed-author:MasiGG, pubmed-author:RulliEE, pubmed-author:RuzzoAA, pubmed-author:SalvatoreLL, pubmed-author:SantiniDD, pubmed-author:StarzWW, pubmed-author:ToniniGG, pubmed-author:VincenziBB
pubmed:issnType	Electronic
pubmed:day	18
pubmed:volume	101
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	715-21
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:19603018-Humans, pubmed-meshheading:19603018-Aged, pubmed-meshheading:19603018-Mutation, pubmed-meshheading:19603018-Female, pubmed-meshheading:19603018-Male, pubmed-meshheading:19603018-Adult, pubmed-meshheading:19603018-Adenocarcinoma, pubmed-meshheading:19603018-Middle Aged, pubmed-meshheading:19603018-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19603018-Tumor Markers, Biological, pubmed-meshheading:19603018-Codon, pubmed-meshheading:19603018-Camptothecin, pubmed-meshheading:19603018-Drug Resistance, Neoplasm, pubmed-meshheading:19603018-Colorectal Neoplasms, pubmed-meshheading:19603018-Antibodies, Monoclonal

More...